Centralized procurement

Explore the landscape of Centralized procurement in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Centralized procurement to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Biokin Scores Triple NMPA Breakthrough Therapy Designation – BL-M07D1, BL-M05D1, and Iza‑Bren Recognized Across Biliary Tract and Gastric Cancers
CompanyDrug

Biokin Scores Triple NMPA Breakthrough Therapy Designation – BL-M07D1, BL-M05D1, and Iza‑Bren Recognized Across Biliary Tract and Gastric Cancers

Sichuan Biokin Pharmaceutical Co., Ltd. (SHA: 688506) announced that its three drug candidates – BL-M07D1, BL-M05D1, and izalontamab bretecan – have been granted Breakthrough Therapy Designation (BTD) by the Center…

Biokin's BL-M12D1 Wins NMPA Clinical Trial Approval – ADC Candidate to Be Evaluated as Monotherapy in Relapsed or Refractory Hematologic Malignancies

Biokin’s BL-M12D1 Wins NMPA Clinical Trial Approval – ADC Candidate to Be Evaluated as Monotherapy in Relapsed or Refractory Hematologic Malignancies

Haisco's HSK42360-Na Granted NMPA Breakthrough Therapy Designation – BRAF Paradoxical Breaker Targets High‑Grade Glioma with BRAF V600 Mutation

Haisco’s HSK42360-Na Granted NMPA Breakthrough Therapy Designation – BRAF Paradoxical Breaker Targets High‑Grade Glioma with BRAF V600 Mutation

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Hefan Medicine's Piracetam Production and Marketing Suspended Over GMP Violations
CompanyDrug

Hefan Medicine’s Piracetam Production and Marketing Suspended Over GMP Violations

Hunan Province Launches Pilot Program for Retail Sales of VBP Drugs with Strict Guidelines
Policy / Regulatory

Hunan Province Launches Pilot Program for Retail Sales of VBP Drugs with Strict Guidelines

CompanyPolicy / Regulatory

China’s NMPA Suspends Dr. Reddy’s Atomoxetine Imports Amid Quality Concerns

Policy / Regulatory

NHSA Mandates Standardized Online Procurement for Injectable Drugs to Ensure Pricing Transparency

Policy / Regulatory

Shenzhen’s Draft Proposal for VBP Drug Procurement and Medical Insurance Fund Management Released

Policy / Regulatory

NHSA Unveils 2024 Medical Procurement Overhaul, Aiming for Synergy Between National and Provincial Levels

CompanyMedical Device

China’s National Procurement Office Announces Continuous VBP for Joint Prosthetics

DrugMedical Device

China’s Health Authorities Investigate Alleged Price Manipulation in Pharma Procurement Tenders

Show More